Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0O6QW
|
||||
| Former ID |
DIB014579
|
||||
| Drug Name |
Manifaxine
|
||||
| Synonyms |
BW-1555U88; GW-320659; GW-320659A
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Major depressive disorder [ICD9: 296.2, 296.3, 710.0; ICD10:F32, F33, M32] | Discontinued in Phase 2 | [546210] | ||
| Company |
Glaxo Wellcome plc
|
||||
| Formula |
C12H15F2NO2
|
||||
| Canonical SMILES |
[C@]1(c2cc(cc(c2)F)F)(OC[C@H](N[C@H]1C)C)O
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Sodium-dependent noradrenaline transporter | Target Info | Modulator | [527845] | |
| Sodium-dependent dopamine transporter | Target Info | Modulator | [527845] | ||
| Pathway Interaction Database | Alpha-synuclein signaling | ||||
| WikiPathways | Monoamine Transport | ||||
| NRF2 pathway | |||||
| Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compoundsWP727:Monoamine Transport | |||||
| Dopaminergic Neurogenesis | |||||
| Parkinsons Disease Pathway | |||||
| Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | |||||
| Neurotransmitter Clearance In The Synaptic Cleft | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.